MedPath

DEPO-MEDROL

DEPO-MEDROL

Approved
DIN Number

00030759

Drug Class

Human

Market Date

Dec 31, 1960

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00030759
AIG Number0106292002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H02AB04 METHYLPREDNISOLONE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntra-Articular ,  Intramuscular ,  Intrasynovial ,  Intralesional
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

METHYLPREDNISOLONE ACETATEActive
Strength: 40 MG / ML
Monograph: METHYLPREDNISOLONE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.